Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
COST PER REPORTABLE RESULT, PATIENT DIAGNOSTIC CHEMISTRY ANALYZER W/CONSUMABLES, UNDER A LEASE AND COMPREHENSIVE SERVICE & SUPPORT AGREEMENT FOR THE PINE RIDGE HOSPITAL LABORATORY. THE PERIOD OF PERFORMANCE FOR DELIVERY WILL BE OCTOBER 17, 2022 T is a federal award for Great Plains Area Indian Health Svc held by Ortho-Clinical Diagnostics, Inc. Estimated value $5M ($8.1M obligated). Current period of performance ends Sep 30, 2024 (potential May 31, 2025). Last award drew 1 bidder. Place of performance: PINE RIDGE SD. Related solicitation TORP 35.
COST PER REPORTABLE RESULT, PATIENT DIAGNOSTIC CHEMISTRY ANALYZER W/CONSUMABLES, UNDER A LEASE AND COMPREHENSIVE SERVICE & SUPPORT AGREEMENT FOR THE PINE RIDGE HOSPITAL LABORATORY. THE PERIOD OF PERFORMANCE FOR DELIVERY WILL BE OCTOBER 17, 2022 T
Recompete timing
PublicCurrent PoP ended Sep 30, 2024 (690 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75H70623F03020?
75H70623F03020 (COST PER reportable RESULT patient diagnostic) is a Great Plains Area Indian Health Svc award with a potential value of $5M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75H70623F03020?
Great Plains Area Indian Health Svc awarded 75H70623F03020 to Ortho-Clinical Diagnostics, Inc (potential $5M).
Who is the incumbent on 75H70623F03020?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2024.
When does Ortho-Clinical Diagnostics, Inc’s 75H70623F03020 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.